6

iShares S&P 500 Health Care Sector UCITS ETF USD (Acc)
Tarjoustasot
Tunnusluvut
Juoksevat kulut
0,15%Omaisuusluokka
OsakeKategoria
Sektori terveydenhuolto osakkeetPerusvaluutta
EUROsinkopolitiikka
KasvuosuudetAvaintietoasiakirja
The investment objective of the Fund is to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the S&P 500 Capped 35/20 Health Care Index. In order to achieve this investment objective, the investment policy of the Fund is to invest in a portfolio of equity securities that as far as possible and practicable consist of the component securities of the S&P 500 Capped 35/20 Health Care Index, this Fund’s Benchmark Index. The Fund intends to replicate the constituents of the Benchmark Index by holding all the securities comprising the Benchmark Index in a similar proportion to their weightings in the Benchmark Index. In order to replicate its Benchmark Index, this Fund may invest up to 20% of its Net Asset Value in shares issued by the same body. This limit may be raised to 35% for a single issuer when exceptional market conditions apply (as set out in section 4 of Schedule III).
Vastaavan tyyppisiä ETF:iä
Omistukset
Jakauma
- Osakkeet99,8%
- Lyhyt korko0,2%
Asiakkaat katsoivat myös
Foorumi
- ·12.5.What do people say about this fund? I'm considering moving some money from the semiconductor ETF over here. Can this potentially outperform the hyped semiconductors, as the health industry has been forgotten in the last couple of years.Had similar thoughts. A good chance this will just be lagging behind though…
- ·27.6.2025Why is this going so badly now?Trump has promised changes to the pharmaceutical industry, but few know exactly what will happen and people then dare not invest. 250631 Trump gave "Astra Zeneca and 16 other pharmaceutical giants 60 days to offer the US customized prices" and Trump says "If you refuse to take responsibility, we will use every tool we have to protect American families from continued abuse of drug pricing." How tariffs and Trump's price pressures will affect US domestic and foreign pharmaceutical companies is not yet known. https://omni.se/trump-skickar-tullbrev-till-lakemedelsjattar-inklijke-astra/a/VzV8mV
Uutiset
Tunnusluvut
Juoksevat kulut
0,15%Omaisuusluokka
OsakeKategoria
Sektori terveydenhuolto osakkeetPerusvaluutta
EUROsinkopolitiikka
KasvuosuudetAvaintietoasiakirja
The investment objective of the Fund is to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the S&P 500 Capped 35/20 Health Care Index. In order to achieve this investment objective, the investment policy of the Fund is to invest in a portfolio of equity securities that as far as possible and practicable consist of the component securities of the S&P 500 Capped 35/20 Health Care Index, this Fund’s Benchmark Index. The Fund intends to replicate the constituents of the Benchmark Index by holding all the securities comprising the Benchmark Index in a similar proportion to their weightings in the Benchmark Index. In order to replicate its Benchmark Index, this Fund may invest up to 20% of its Net Asset Value in shares issued by the same body. This limit may be raised to 35% for a single issuer when exceptional market conditions apply (as set out in section 4 of Schedule III).
Vastaavan tyyppisiä ETF:iä
Uutiset
Tarjoustasot
Omistukset
Jakauma
- Osakkeet99,8%
- Lyhyt korko0,2%
Asiakkaat katsoivat myös
Foorumi
- ·12.5.What do people say about this fund? I'm considering moving some money from the semiconductor ETF over here. Can this potentially outperform the hyped semiconductors, as the health industry has been forgotten in the last couple of years.Had similar thoughts. A good chance this will just be lagging behind though…
- ·27.6.2025Why is this going so badly now?Trump has promised changes to the pharmaceutical industry, but few know exactly what will happen and people then dare not invest. 250631 Trump gave "Astra Zeneca and 16 other pharmaceutical giants 60 days to offer the US customized prices" and Trump says "If you refuse to take responsibility, we will use every tool we have to protect American families from continued abuse of drug pricing." How tariffs and Trump's price pressures will affect US domestic and foreign pharmaceutical companies is not yet known. https://omni.se/trump-skickar-tullbrev-till-lakemedelsjattar-inklijke-astra/a/VzV8mV
Tunnusluvut
Juoksevat kulut
0,15%Omaisuusluokka
OsakeKategoria
Sektori terveydenhuolto osakkeetPerusvaluutta
EUROsinkopolitiikka
KasvuosuudetAvaintietoasiakirja
The investment objective of the Fund is to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the S&P 500 Capped 35/20 Health Care Index. In order to achieve this investment objective, the investment policy of the Fund is to invest in a portfolio of equity securities that as far as possible and practicable consist of the component securities of the S&P 500 Capped 35/20 Health Care Index, this Fund’s Benchmark Index. The Fund intends to replicate the constituents of the Benchmark Index by holding all the securities comprising the Benchmark Index in a similar proportion to their weightings in the Benchmark Index. In order to replicate its Benchmark Index, this Fund may invest up to 20% of its Net Asset Value in shares issued by the same body. This limit may be raised to 35% for a single issuer when exceptional market conditions apply (as set out in section 4 of Schedule III).
Vastaavan tyyppisiä ETF:iä
Uutiset
Foorumi
- ·12.5.What do people say about this fund? I'm considering moving some money from the semiconductor ETF over here. Can this potentially outperform the hyped semiconductors, as the health industry has been forgotten in the last couple of years.Had similar thoughts. A good chance this will just be lagging behind though…
- ·27.6.2025Why is this going so badly now?Trump has promised changes to the pharmaceutical industry, but few know exactly what will happen and people then dare not invest. 250631 Trump gave "Astra Zeneca and 16 other pharmaceutical giants 60 days to offer the US customized prices" and Trump says "If you refuse to take responsibility, we will use every tool we have to protect American families from continued abuse of drug pricing." How tariffs and Trump's price pressures will affect US domestic and foreign pharmaceutical companies is not yet known. https://omni.se/trump-skickar-tullbrev-till-lakemedelsjattar-inklijke-astra/a/VzV8mV
Tarjoustasot
Omistukset
Jakauma
- Osakkeet99,8%
- Lyhyt korko0,2%

